PMID- 24161444 OWN - NLM STAT- MEDLINE DCOM- 20150106 LR - 20211203 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 67 DP - 2014 Feb TI - Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms. PG - 171-87 LID - S0891-5849(13)01477-9 [pii] LID - 10.1016/j.freeradbiomed.2013.10.810 [doi] AB - Activation of the aryl hydrocarbon receptor (AhR) ultimately leads to the induction of the carcinogen-activating enzyme cytochrome P450 1A1 (CYP1A1), and activation of the nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) in addition to the AhR pathway induces the expression of the NADP(H):quinone oxidoreductase (NQO1). Therefore, the aim of this study was to examine the effect of As(III) pentavalent metabolites, MMA(V), DMA(V), and TMA(V), on AhR and Nrf2 activation and on the expression of their prototypical downstream targets CYP1A1 and NQO1, respectively. Our results showed that treatment of HepG2 cells with MMA(V), DMA(V), or TMA(V) in the absence and presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin or sulforaphane significantly induced both CYP1A1 and NQO1 at the mRNA, protein, and catalytic activity levels. Furthermore, these metabolites increased the AhR-dependent XRE-driven and the Nrf2-dependent ARE-driven luciferase reporter activities, which coincided with increased nuclear accumulation of both transcription factors. However, none of these metabolites were shown to be AhR ligands. The induction of CYP1A1 by these metabolites seems to be ligand-independent, possibly through a decrease in HSP90 protein expression levels. The metabolites also increased ROS production, which was significantly higher than that produced by As(III). Upon knockdown of AhR and Nrf2 the MMA(V)-, DMA(V)-, and TMA(V)-mediated induction of both CYP1A1 and NQO1 proteins was significantly decreased. In conclusion, this study demonstrates for the first time that methylated pentavalent arsenic metabolites are bifunctional inducers, as they increase CYP1A1 by activating the AhR/XRE signaling pathway and they increase NQO1 by activating the Nrf2/ARE signaling pathway in addition to the AhR/XRE pathway. CI - (c) 2013 Elsevier Inc. All rights reserved. FAU - Anwar-Mohamed, Anwar AU - Anwar-Mohamed A AD - Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1. FAU - Elshenawy, Osama H AU - Elshenawy OH AD - Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1. FAU - Soshilov, Anatoly A AU - Soshilov AA AD - Department of Environmental Toxicology, University of California at Davis, Davis, CA 95616, USA. FAU - Denison, Michael S AU - Denison MS AD - Department of Environmental Toxicology, University of California at Davis, Davis, CA 95616, USA. FAU - Chris Le, X AU - Chris Le X AD - Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada T6G 2G3. FAU - Klotz, Lars-Oliver AU - Klotz LO AD - Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1. FAU - El-Kadi, Ayman O S AU - El-Kadi AO AD - Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1; College of Pharmacy, Qatar University, Doha 02713, Qatar. Electronic address: aelkadi@ualberta.ca. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131024 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Arsenicals) RN - 0 (HSP90 Heat-Shock Proteins) RN - 0 (Isothiocyanates) RN - 0 (NF-E2-Related Factor 2) RN - 0 (NFE2L2 protein, human) RN - 0 (Polychlorinated Dibenzodioxins) RN - 0 (Receptors, Aryl Hydrocarbon) RN - 0 (Sulfoxides) RN - EC 1.13.12.- (Luciferases) RN - EC 1.14.14.1 (CYP1A1 protein, human) RN - EC 1.14.14.1 (Cytochrome P-450 CYP1A1) RN - EC 1.6.5.2 (NAD(P)H Dehydrogenase (Quinone)) RN - EC 1.6.5.2 (NQO1 protein, human) RN - GA49J4310U (sulforaphane) SB - IM MH - Antioxidant Response Elements MH - Arsenicals/*pharmacology MH - Cytochrome P-450 CYP1A1/*genetics/metabolism MH - Gene Expression Regulation MH - Genes, Reporter MH - HSP90 Heat-Shock Proteins/genetics/metabolism MH - Hep G2 Cells MH - Humans MH - Isothiocyanates/pharmacology MH - Luciferases/genetics/metabolism MH - Methylation MH - NAD(P)H Dehydrogenase (Quinone)/*genetics/metabolism MH - NF-E2-Related Factor 2/*genetics/metabolism MH - Polychlorinated Dibenzodioxins/pharmacology MH - Receptors, Aryl Hydrocarbon/*genetics/metabolism MH - Signal Transduction/*drug effects MH - Sulfoxides OTO - NOTNLM OT - ARE OT - AhR OT - Arsenic OT - CYP1A1 OT - Free radicals OT - NQO1 OT - Nrf2 OT - XRE EDAT- 2013/10/29 06:00 MHDA- 2015/01/07 06:00 CRDT- 2013/10/29 06:00 PHST- 2013/06/03 00:00 [received] PHST- 2013/09/29 00:00 [revised] PHST- 2013/10/16 00:00 [accepted] PHST- 2013/10/29 06:00 [entrez] PHST- 2013/10/29 06:00 [pubmed] PHST- 2015/01/07 06:00 [medline] AID - S0891-5849(13)01477-9 [pii] AID - 10.1016/j.freeradbiomed.2013.10.810 [doi] PST - ppublish SO - Free Radic Biol Med. 2014 Feb;67:171-87. doi: 10.1016/j.freeradbiomed.2013.10.810. Epub 2013 Oct 24.